Carfilzomib/Daratumumab/Dexamethasone Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of carfilzomib, daratumumab and dexamethasone that can be used for the treatment of relapsed or refractory plasma cell (multiple) myeloma.

**Synonyms:** - Carfilzomib-Daratumumab-Dexamethasone - Carfilzomib-Daratumumab-Dexamethasone Regimen - Carfilzomib-Dexamethasone Plus Daratumumab - Carfilzomib-Dexamethasone-Daratumumab - Carfilzomib/Daratumumab/Dexamethasone - Carfilzomib/Dexamethasone Plus Daratumumab - Carfilzomib/Dexamethasone/Daratumumab - Dara-Kd - Dara-Kd (SC daratumumab) - Daratumumab Plus KD Regimen - Daratumumab-KD Regimen - Darzalex-KD Regimen - Kyprolis/Dexamethasone/Darzalex